Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
As a dual amylin and calcitonin receptor agonist, cagrilintides mechanism of action centers on binding to the calcitonin receptor (CTR) and the amylin receptor subtypes AMYR, AMYR, and AMYR each formed by the CTR partnered with receptor-activity modifying proteins RAMP1, RAMP2, or RAMP3, respectively
Science A major endogenous antioxidant produced by cells
Research from various laboratories worldwide has demonstrated that the tri-peptide GHK-Cu offers multiple biological effects, such as promoting wound healing, attracting immune cells, reducing inflammation and oxidative stress, and facilitating the production of collagen and glycosaminoglycan in skin cells while promoting blood vessel growth
US$ 24.50
US$ 20.96
US$ 27.20
US$ 27.98
